Skip to content

Béa Applicator and Béa Cervical Cap Safety and Usability Study

Béa Applicator and Béa Cervical Cap Usability Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05129553
Enrollment
40
Registered
2021-11-22
Start date
2022-03-01
Completion date
2022-09-30
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Safety and Usability

Brief summary

This is a Clinical Study Designed to Validate the Usability and Safety of the Over-the-counter (OTC) Béa Applicator and Béa Cervical Cap Device in a Home Use Environment.

Detailed description

Female participants will undergo a baseline physical assessment performed by a physician at the study site. The participants will then be given the Béa Applicator and Béa Cervical Cap device with accompanying instructions and a semen collection pot. The participants will return home to use the device as per the Instruction for Use (IFU). The Béa Cervical Cap will remain in place for a minimum of 4 hours and a maximum of 6 hours. At the follow-up assessment, the investigator will investigate all primary objectives via a physical exam or via questioning the participant.

Interventions

DEVICEBéa Applicator and Béa Cervical Cap Device

Single-use of the investigational device

Sponsors

StepOne Fertility
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* People who are able to and for whom it is medically safe to conceive * Heterosexual couples and individuals, of any race or ethnicity, who are sexually active * 18 - 40 years of age * Trying to conceive * Signed Informed Consent * Approximately nineteen per cent (19%) of participants will present with a retroverted uterus as found in the general female population.

Exclusion criteria

* Vaginal prolapse (female) * Hysterectomy (female) * Erectile dysfunction (male) * Diagnosis and/or treatment of vaginitis or sexually transmitted infection (STI) within the last month * Colposcopy with biopsy surgery within the last three (3) months (female) * Treatment for dysplasia surgery within the previous three (3) months (female) * Vaginal/cervical surgery within the last three (3) months (female) * Current pregnancy (female) * Unable to read and understand English, as assessed by REALM * Presence of noticeable lesions, open sores, viral warts, and any other genital abnormalities (female & male)

Design outcomes

Primary

MeasureTime frameDescription
Correctly place semen in the device0.5 hrsParticipants indicate an ability to collect and transfer semen into the device in the intended use environment (at-home).
Correctly inserting the device into the vagina1 hrsParticipants indicate an ability to insert the device into the vagina, in the intended use environment (at-home).
Correctly positioning of the device over the cervical os4-6 hrsA clinical examination by a physician to confirm the device is positioned over the cervical os.
Correctly withdraw the device from the vagina4-6 hrsParticipants indicate an ability to withdraw the device from the vagina with the use of the removal string.
The device causes trauma or harm4-6 hrsAfter the device is removed from the vagina, a physician assessment via a speculum examination to determine if the device caused trauma or harm to the vaginal epithelium or cervix.
Presence of semen in the cap4-6 hrsAfter the device is removed from the vagina, a physician assesses the presence of semen remaining in the cervical cap.
Correctly dispose of the used device after use4-6 hrsParticipants indicate an ability to dispose of the device after use.
Correctly avoid sexual activity while the device is in place4-6 hrsParticipants indicate an ability to avoid sexual activity while the device is on the cervical os.

Contacts

Primary ContactDavid G O'Rourke
david@beafertility.com0044 7445338259

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026